The insulin delivery devices market is estimated to reach US$16.8744 billion by 2024 from US$11.231 billion in 2018 growing at a CAGR of 7.02%. Insulin Delivery Devices are used to administer insulin to the diabetic patients. There are many different types of insulin delivery devices available including syringes, delivery devices, jet injectors, oral insulin and pumps etc. giving patients number of options to decide as per their ease and convenience. Alternate forms of insulin delivery are being developed to overcome problems with current subcutaneous insulin injection therapy like poor compliance due to pain, variable absorption lack of feedback control. Insulin Delivery Devices market will show robust growth during the forecast period owing to the rising prevalence of the diabetes because of sedentary life style and rising number of geriatric population across the globe. Continuous technological innovations and advancements in insulin delivery devices for increasing patient compliance will also boost the adoption of the Insulin Delivery Devices during the given forecast period. Poor reimbursement structure and insurance coverage in developing countries might restrain the growth of the Insulin Delivery Devices market during the given time frame.
The Insulin Delivery Devices Market - Forecasts from 2019 to 2024 is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by types, application, end users and geography.
The insulin delivery devices market has been segmented based on by types, application, and geography. By types, the market is segmented as insulin pens, syringes, insulin pumps, inhalers and others. By application, market is segmented as type I diabetes, type II diabetes and gestational diabetes. On the basis of end users market is segmented as hospitals and clinics, ambulatory care settings and home care settings.
Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and Asia Pacific. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major industry players profiled as part of the report are Novo Nordisk, Becton, Dickinson and Company, Medtronic, Sanofi, and ELI Lilly and Company among others.
Segmentation
By Types
By Application
By End Users
By Geography
North America
Europe
Middle East and Africa
The report will be delivered in 3 working days.
The Insulin Delivery Devices Market - Forecasts from 2019 to 2024 is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by types, application, end users and geography.
The insulin delivery devices market has been segmented based on by types, application, and geography. By types, the market is segmented as insulin pens, syringes, insulin pumps, inhalers and others. By application, market is segmented as type I diabetes, type II diabetes and gestational diabetes. On the basis of end users market is segmented as hospitals and clinics, ambulatory care settings and home care settings.
Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and Asia Pacific. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major industry players profiled as part of the report are Novo Nordisk, Becton, Dickinson and Company, Medtronic, Sanofi, and ELI Lilly and Company among others.
Segmentation
By Types
- Insulin Delivery devices
- Syringes
- Insulin Pumps
- Inhalers
- Others
By Application
- Type I Diabetes
- Type II Diabetes
- Gestational Diabetes
By End Users
- Hospitals and Clinics
- Ambulatory Care Settings
- Home Care Settings
By Geography
North America
- U.S.
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
Europe
- UK
- Germany
- France
- Spain
- Others
Middle East and Africa
- UAE
- Israel
- Others
- Asia-Pacific
- Japan
- China
- India
- South Korea
- Others
The report will be delivered in 3 working days.
Table of Contents
1. Introduction
2. RESEARCH METHODOLOGY
4. MARKET DYNAMICS
5. INSULIN DELIVERY DEVICES MARKET BY TYPES
6. INSULIN DELIVERY DEVICES MARKET BY APPLICATION
7. INSULIN DELIVERY DEVICES MARKET BY END USERS
8. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET FORECAST AND TRENDS
9. SOUTH AMERICA INSULIN DELIVERY DEVICES MARKET
10. EUROPE INSULIN DELIVERY DEVICES MARKET
11. MIDDLE EAST AND AFRICA INSULIN DELIVERY DEVICES MARKET
12. ASIA PACIFIC INSULIN DELIVERY DEVICES MARKET
13. COMPETITIVE INTELLIGENCE
14. COMPANY PROFILES
Companies Mentioned
- Novo Nordisk
- Becton, Dickinson and Company
- Medtronic
- Sanofi
- ELI Lilly and Company
- Ypsomed AG
- Biocon Limited
- Insulet Corporation
- Tandem Diabetes Care, Inc.
- F. Hoffmann-La Roche Ltd
Methodology
LOADING...